On the fast-acting insulin side, Halozyme had a number of encouraging presentations. The company is attempting to produce faster-acting insulin by adding an enzyme (PH20) that would temporarily degrade connective tissue in the skin, allowing insulin to be absorbed more quickly.*
I think if I'd be horrified if I found out how all my gear and meds actually worked.
* Quotation from the latest issue - #44 - of diaTribe's newsletter. Get it here!